Skip to content

Effect of a Non-Invasive Brain Stimulation Technique on Smoking Cessation Behaviors

Effect of a Non-Invasive Brain Stimulation Technique on Smoking Cessation Behaviors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03386253
Enrollment
16
Registered
2017-12-29
Start date
2018-01-01
Completion date
2018-11-21
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use Disorder

Brief summary

In this pilot study, the feasibility of using tDCS (a non-invasive brain stimulation technique) while performing a task requiring cognitive flexibility will be examined in smokers and initial data will be collected regarding the effect of tDCS on smoking cessation behaviors. Smokers will be randomized to receive either active or sham tDCS daily for 5 days after which they will attempt to quit smoking. Smoking behavior after the attempted quit date will be assessed at four weekly visits.

Interventions

DEVICEactive tDCS

two 13 minute tDCS sessions separated by 20 minutes in between

DEVICEsham tDCS

sham tDCS session given for same length of time as active

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DEVICE_FEASIBILITY
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Be between the ages of 18 and 64 * Smoked (on average) at least 5 cigarettes per day * Be motivated to quit smoking

Exclusion criteria

* Unstable medical or psychiatric conditions * Any medical conditions with neurological sequelae * History of loss of consciousness of greater than 30 minutes duration or loss of consciousness with neurological sequelae * Have any medical condition or use any medication that would either increase risk of subjects participating in this study (e.g., medications that lower the seizure threshold) or that would impact measures of interest (e.g. smoking cessation medications). * Are pregnant or planning to become pregnant during the study * Current use of pacemaker, intracranial electrodes or implanted defibrillator

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Willing to Complete 5 Days of tDCS or Sham5 daysAs a feasibility study, the primary endpoint will be to determine if smokers are willing to enroll into and complete a study evaluating tDCS. Number of smokers enrolled and number who complete the 5 day tDCS procedures will be assessed.

Secondary

MeasureTime frameDescription
Change in Number of Cigarettes Smoked Per Day4 weeksChange in number of cigarettes smoked per day from the 1 week training period to the 4 week post quit period.

Countries

United States

Participant flow

Participants by arm

ArmCount
Active tDCS
Participants receive active tDCS for five consecutive days before attempting to quit smoking active tDCS: two 13 minute tDCS sessions separated by 20 minutes in between
8
Sham tDCS
Participants receive sham tDCS for five consecutive days before attempting to quit smoking sham tDCS: sham tDCS session given for same length of time as active
8
Total16

Baseline characteristics

CharacteristicActive tDCSTotalSham tDCS
Age, Continuous44.9 years
STANDARD_DEVIATION 10.3
45.9 years
STANDARD_DEVIATION 11.6
47.0 years
STANDARD_DEVIATION 13.3
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants1 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants15 Participants8 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants3 Participants1 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
3 Participants7 Participants4 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
3 Participants5 Participants2 Participants
Region of Enrollment
United States
8 participants16 participants8 participants
Sex: Female, Male
Female
6 Participants11 Participants5 Participants
Sex: Female, Male
Male
2 Participants5 Participants3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 8
other
Total, other adverse events
6 / 84 / 8
serious
Total, serious adverse events
0 / 80 / 8

Outcome results

Primary

Number of Participants Willing to Complete 5 Days of tDCS or Sham

As a feasibility study, the primary endpoint will be to determine if smokers are willing to enroll into and complete a study evaluating tDCS. Number of smokers enrolled and number who complete the 5 day tDCS procedures will be assessed.

Time frame: 5 days

Population: Number randomized

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Active tDCSNumber of Participants Willing to Complete 5 Days of tDCS or Sham7 Participants
Sham tDCSNumber of Participants Willing to Complete 5 Days of tDCS or Sham8 Participants
Secondary

Change in Number of Cigarettes Smoked Per Day

Change in number of cigarettes smoked per day from the 1 week training period to the 4 week post quit period.

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
Active tDCSChange in Number of Cigarettes Smoked Per Day-4.03 cigarettes per dayStandard Error 1.02
Sham tDCSChange in Number of Cigarettes Smoked Per Day-4.47 cigarettes per dayStandard Error 1.09
p-value: 0.77ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026